Market and Trading Information for CARNA BIOSCIENCES INC (Japan)
The following details are available for trading and market data about the stock of CARNA BIOSCIENCES INC as of writing. Currency is JPY.
Current Share Price:
JPY ¥ 522.00
Previous Year's Closing Price:
JPY ¥ 520.00
Percentage Price Change (YTD):
0.38%
Market Cap:
JPY ¥ 8.95 billion
52-week Price Range:
447 - 1060
Dividend Per Share:
0
EPS (TTM):
-114.27
Price-Earnings (Trailing):
0
Price-Earnings (Forward):
4.63
Currency:
JPY
Company Profile and Business Description for CARNA BIOSCIENCES INC
Carna Biosciences, Inc. provides drug discovery supporting products and services in Japan. Its products and services include kinase proteins; biotinylated kinases to use in the study of kinase-molecule interactions; substrates; kinase protein assay kits; profiling services; NanoBRET TE intracellular kinase cell-based assay services; protein detection and interaction services; tyrosine kinase cell-based assay services; ClariCELL kinase cell-based assay services; crystallization services; custom production of ultra-pure proteins for crystallography; weak affinity chromatography; and live-cell kinase assays. It also identifies and develops medicines primarily for the treatment of cancer and inflammatory diseases using its QuickScout drug discovery platform. The company has a research and development collaboration with Gilead Sciences, Inc. to develop and commercialize small molecule compounds in immuno-oncology. Carna Biosciences, Inc. was founded in 2003 and is based in Kobe, Japan.
Stock Screener for Japan Stocks (Sector-wise)
Peer / Competitor Companies of Biotechnology Sector of Japan
Along with Carna Biosciences, Inc., the following other peer (competitor) companies also exist within the same Biotechnology - Healthcare sector of Japan whose company profile and dividend history is as follows:
▶ ANGES INC (4563): AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene-based medical products. Its lead product is Hepatocyte....See Detailed Company Profile
▶ BRIGHTPATH BIOTHERAPEUTICS CO L (4594): BrightPath Biotherapeutics Co., Ltd. develops cancer immunotherapy drugs. It develops ITK-1, a cancer peptide vaccine, which is in Phase III....See Detailed Company Profile
▶ CANBAS Co (4575): CanBas Co., Ltd., a clinical stage biopharmaceutical company, develops therapeutics for cancer patients. The company develops CBP501, a....See Detailed Company Profile
▶ CELLSEED INC (7776): CellSeed Inc. develops regenerative medicine products primarily in Japan and Europe. It is involved in the research, development, manufacture,....See Detailed Company Profile
▶ CELLSOURCE Co (4880): CellSource Co., Ltd. manufactures regenerative medicines. The company was founded in 2015 and is based in Tokyo,....See Detailed Company Profile
▶ CHIOME BIOSCIENCE INC (4583): Chiome Bioscience Inc. engages in the research and development of drug discovery technology platform worldwide. The company provides drug....See Detailed Company Profile
▶ D.WESTERN THERAPEUTICS (4576): D. Western Therapeutics Institute, Inc., a biotechnology company, focuses on developing drugs to serve patients worldwide. The company offers....See Detailed Company Profile
▶ DELTA FLY PHARMA INC (4598): Delta-Fly Pharma, Inc. engages in the discovery and development of gentle anti-cancer agents worldwide. The company was founded in 2010 and is....See Detailed Company Profile
▶ GENE TECHNO SCIENCE CO LIMITED (4584): Gene Techno Science Co.,Ltd. develops pharmaceuticals for the treatment of rare and intractable diseases. Its pipeline products include GND-001....See Detailed Company Profile
▶ GNI GROUP LTD (2160): GNI Group Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical drugs and....See Detailed Company Profile
▶ HEALIOS KK (4593): Healios K.K. engages in the research and development, and manufacture of cell therapy and regenerative medicine products in Japan, Europe, and....See Detailed Company Profile
▶ HUMAN METABOLOME TECHNOLOGIES I (6090): Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and....See Detailed Company Profile
▶ IMMUNO-BIOLOGICAL LABORATORIES (4570): Immuno-Biological Laboratories Co., Ltd. engages in the research, development, manufacture, and supply of various immunological research....See Detailed Company Profile
▶ INA RESEARCH INC (2176): Ina Research Inc., a consulting company, provides non-clinical and clinical studies services primarily in Japan. It offers toxicity studies for....See Detailed Company Profile
▶ JAPAN TISSUE ENGINEERING Co (7774): Japan Tissue Engineering Co., Ltd. engages in the regenerative medicine business in Japan. The company offers autologous cultured epidermis and....See Detailed Company Profile
▶ KUBOTA PHARMACEUTICAL HLDGS CO (4596): Kubota Pharmaceutical Holdings Co., Ltd. develops a portfolio of drugs and devices to preserve and restore vision worldwide. Its product....See Detailed Company Profile
▶ LINICAL Co (2183): Linical Co., Ltd. provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies....See Detailed Company Profile
▶ MEDICAL & BIO LABS (4557): Medical & Biological Laboratories Co., Ltd. researches, develops, manufactures, and sells in vitro diagnostics and research reagents worldwide.....See Detailed Company Profile
▶ MEDICINOVA INC (4875): MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases....See Detailed Company Profile
▶ MEDINET Co (2370): MEDINET Co., Ltd. operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy....See Detailed Company Profile